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Chrysotile Asbestos and 
Mesothelioma
doi:10.1289/ehp.1002446
The Editor’s Summary for the article by Tse 
et al. (2010) stated the following: 
Assuming an average latency of 42 years, the 
authors predict that incidence rates will peak 
in 2009 and that diagnoses will peak in 2014. 
However, they caution that ongoing use of 
chrysotile asbestos (which has been implicated 
but not conclusively established as a cause of 
mesothelioma) and the release of asbestos fibers 
from older buildings during demolition or reno­
vation may slow the projected decline.
The statement concerning chrysotile asbes­
tos being “implicated but not conclusively 
established as a cause of mesothelioma” is 
inconsistent with current scientific opinion. 
I refer you to the most recent evaluation by 
the International Agency for Research on 
Cancer in which Straif et al. (2009) stated, 
Epidemiological evidence has increasingly shown 
an association of all forms of asbestos (chryso­
tile, crocidolite, amosite, tremolite, actinolite, 
and anthophyllite) with an increased risk of lung 
cancer and mesothelioma. Although the potency 
differences with respect to lung cancer or meso­
thelioma for fibres of various types and dimen­
sions are debated, the fundamental conclusion 
is that all forms of asbestos are “carcinogenic to 
humans” (Group 1).
In addition, opinions such as that 
expressed in the Editor’s Summary are 
advanced only by scientists with pro  chrysotile 
industry bias. 
When I wrote the draft for the first IARC 
Monograph on asbestos in 1976, which the 
expert committee accepted and published in 
1977 as IARC Monograph Volume 14, a simi­
lar conclusion was stated: “Many pleural and 
peritoneal mesotheliomas have been observed 
after occupational exposure to crocidolite, 
amosite and chrysotile.” Since then—more 
than 30 years—science has not changed its 
opinion that all forms of asbestos, including 
chrysotile, cause mesothelioma. 
In fact, in the article that is the subject of 
the Editor’s Summary, Tse et al. (2010) did 
not indicate that chrysotile is not a cause of 
mesothelioma; on the contrary, they stated 
the following: 
Although the mesothelioma incidence is antici­
pated to decline in the coming decades, it may 
not decrease to background risk levels given that 
chrysotile consumption has not been banned 
under the current legislation and that second­
ary asbestos exposure from the environment will 
likely continue. Nevertheless, the hypotheses 
generated from this ecologic study need further 
confirmation by subsequent analytic studies. The 
present study provides supportive evidence for an 
immediate and global ban on asbestos use.
I hope that future Editor’s Summaries 
will reflect the conclusions of the article and 
not put forth statements that are not sup­
ported by mainstream science. I also support 
the conclusion of Tse e al. (2010) for “an 
immediate and global ban on asbestos use.”
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Editor’s Note: We appreciate Lemen’s con-
cern about the incorrect statement that was 
included in the original Editor’s Summary 
for Tse et al. (2010), and we regret the error. 
The Editor’s Summary has been corrected in 
the online version of the paper, and an erra-
tum was published in the June issue of EHP 
[118:A240 (2010)]; the text of the erratum is 
included below:
The Editor’s Summary for the article “Are Current 
or Future Mesothelioma Epidemics in Hong Kong 
the Tragic Legacy of Uncontrolled Use of Asbestos 
in the Past?” by Tse et al. [Environ Health Perspect 
118:382–386 (2010); doi:10.1289/ehp.0900868], 
has been corrected online: specifically, “(which has 
been implicated but not conclusively established as a 
cause of mesothelioma)” has been deleted. 
The Role of DDT in Malaria 
Control
doi:10.1289/ehp.1002279
The letter “DDT and Malaria Control” 
(Tren and Roberts 2010) is the latest in 
a long string of opinion pieces placed by 
authors associated with Africa Fighting 
Malaria (AFM). Appearing in both the 
popular media (e.g., AFM 2006; Bate 2009; 
Bate and De Lorenzo 2007; Roberts 2007a; 
Tren 2002) and scientific literature (e.g., 
Attaran et al. 2000; Roberts 2001, 2007b; 
Roberts et al. 2000, 2004; Tren 2009), these 
articles and letters reduce the complex issue 
of malaria control to a single, dichotomous 
choice between DDT and malaria. Framing 
the issue in this manner is a dangerous over­
simplification and an distraction from the 
critical dialog on how to effectively combat 
malaria around the world—particularly in 
African communities. 
The question that AFM and malaria con­
trol experts must ask is not “Which is worse, 
malaria or DDT?” but rather “What are the 
best tools to deploy for malaria control in a 
given situation, taking into account the on­
the­ground challenges and needs, efficacy, 
cost, and collateral effects—both positive and 
negative—to human health and the environ­
ment, as well as the uncertainties associated 
with all these considerations?”
Tren and Roberts (2010) briefly acknowl­
edged that alternatives to DDT exist (while 
denigrating them as “supposed solutions”), 
but in typical fashion they focused most of 
their letter on the chemical, arguing that 
the health effects of malaria are much worse 
that those of DDT exposure. As malaria 
professionals we are well aware of the dire 
health consequences of malaria, but also of 
DDT. The challenge before us is therefore to 
  determine how much weight to give to vec­
tor control within the broader context of a 
malaria control program; within vector con­
trol, how much weight to allot to nets versus 
indoor residual spraying (IRS); and within 
IRS, how much weight to give to DDT or 
some other chemical.
These decisions are indeed complex and 
location specific. In this regard, van den 
Berg’s commentary, “Global Status of DDT 
and Its Alternatives for Use in Vector Control 
to Prevent Disease” (van den Berg 2009), is a 
most useful contribution. In contrast, Tren 
and Roberts’ (2010) advice that “van den 
Berg’s concerns should be ignored” strikes us 
as reckless and irresponsible. 
In 2006, Allan Schapira, former coor­
dinator of vector control and prevention 
of World Health Organization’s Global 
Malaria Programme, observed that malaria 
control discussions had become “polluted,” 
and warned, “The renewed interest in indoor 
residual spraying could lead to interminable 
debates in countries about the pros and cons 
of DDT” (Schapira 2006). However well 
intentioned, Tren and Roberts (2010)—as 
with much of AFM’s output—do more to 
fuel those “interminable debates” than to 
meaningfully inform decisions that will save 
people’s lives. 
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DDT in Malaria Control: 
Roberts and Tren Respond
doi:10.1289/ehp.1002279R
Herren and Mbogo’s critique of our response 
(Tren and Roberts 2010) to van den Berg 
(2009) is lacking in substance. In their letter, 
they attack our work by characterizing our 
advocacy for using DDT to control malaria 
as a distraction from larger malaria control 
issues. These authors apparently discount the 
fact that some African countries are presently 
making highly effective use of DDT to reduce 
both malaria deaths and malaria infections. 
Countries that use DDT benefit from its spa­
tial repellent action that stops mosquitoes from 
entering houses and transmitting disease, and 
no alternative insecticide does this (Roberts and 
Tren 2010). In addition, Herren and Mbogo 
apparently do not understand that our advo­
cacy is consistent with that exhibited by the 
malaria control community, with hundreds 
signing a petition to prevent DDT elimination 
through Stockholm Convention negotiations. 
If DDT had been eliminated, countries pres­
ently using DDT would have been deprived 
of its benefits for protecting health and sav­
ing lives. Herren and Mbogo claim that our 
response to van den Berg’s commentary (van 
den Berg 2009) was fixated on DDT, in lieu of 
addressing the larger issues of what should be 
done to control malaria. In our letter (Roberts 
and Tren 2010), we addressed what we con­
sidered to be an attack on DDT use. How 
could we have responded without addressing 
the issues in van den Berg’s commentary?
Herren and Mbogo mischaracterize 
our position vis­à­vis DDT and alternative 
insecticides by asserting that we are reduc­
ing the malaria control debate to a simplis­
tic equation of malaria or DDT. In fact, we 
have a public record of supporting the use of 
  insecticide­treated nets and the use of alterna­
tive insecticides for malaria control. However, 
we have repeatedly emphasized that, for obvi­
ous reasons, insecticide­treated nets are not 
the only solution for malaria control. In fact, 
we object to a theme of nets and nets alone as 
much as we would object to a theme of DDT 
and DDT alone. Basically, there is no single­
solution approach to malaria control. All tools 
are needed—not just those that are currently 
in vogue. 
Herren and Mbogo state that they are fully 
aware that malaria is a worse outcome than 
possible health effects of DDT. We agree with 
them and appreciate their willingness to admit 
this, because their admission opposes published 
specu  lations that DDT might be causing more 
harm than good (Chen and Rogan 2003).
Herren and Mbogo conclude that we 
“do more to fuel those ‘interminable debates’ 
[DDT or no DDT for malaria control] than 
to meaningfully inform decisions that will 
save people’s lives.” It seems that these authors 
ignore the fundamental fact that we do not 
elaborate on alternative approaches to malaria 
control because the alternatives are not pres­
ently under threat of elimination. The alter­
natives are being used and should continue 
to be used, but the future is far less certain 
for DDT. Advocacy saved DDT from being 
eliminated during the original negotiations for 
the Stockholm Convention, and lives are being 
saved and diseases prevented as a consequence. 
The idea that the threat is over and that DDT 
is now available to those countries making 
effective use of it is wrong. The Stockholm 
Convention Secretariat is now planning to stop 
all production of DDT in 2017 and eliminate 
it entirely from use in malaria control programs 
in 2020 (UN Environment Program 2010). 
The Stockholm Convention Secretariat plans 
to prevent future uses of DDT, even though 
there is no cost­effective replacement for 
DDT. Given these circumstances, Herren and 
Mbogo should expect the interminable debates 
to become even more polemic in the future.
As for the big issues of what should be 
done to control malaria, our position is 
clear: Decisions should be based on scientific 
evidence of what actually works, on local 
circum  stances, and on what proves to be 
the most cost­effective in terms of reducing   
disease and preventing human deaths.
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Traffic-Related Air Pollution 
and Childhood Asthma
doi:10.1289/ehp.1002224
We congratulate Clark et al. (2010) for their 
interesting article concerning traffic­related 
air pollution and asthma in children. They 
examined early­life (in utero and during the 
first year of life) exposure to traffic­related air   
pollution in a large population­based study 
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(a nested case–control study including nearly 
3,500 children). The authors found an asso­
ciation between elevated early­life exposure 
to traffic­related air pollution and a higher 
risk of asthma in preschool­aged children. 
However, Clark et al. (2010) address aspects, 
raise questions, and give results that deserve 
further comment—both concerning specific 
items and general “structural” criteria used 
in epidemiological studies on adverse health 
effects from air pollution. 
Recent reports have suggested that indi­
vidual susceptibility could play a previously 
unsuspected role in the occurrence of diseases 
(Cetta et al. 2009a), perhaps a role greater 
than that of the intrinsic toxicity of pollut­
ants (Cetta et al. 2009b). This could explain, 
at least in part, why it is so difficult to deter­
mine a precise threshold concentration that is 
harmful or safe for each individual (Cetta et al. 
2007). But this is just one side of the question.
The main question is that, in the absence 
of adequate and specific markers of exposure, 
effect and susceptibility, the linear dose and 
effect model, and the concomitant pollut­
ant concentration and disease occurrence 
relation  ship cannot explain the complexity 
of the phenomenon of host–particle inter­
actions. In particular, initial cell alterations 
(e.g., oxidative stress, DNA adduct forma­
tion) rarely turn into permanent tissue dam­
age and evident disease because of host repair 
and defence mechanisms.
In their article Clark et al. (2010) noted 
another important aspect that should be con­
sidered when comparing pollutant concentra­
tions with the burden of deleterious effects, 
both at the individual and population levels: 
acute effects of peak concentrations of pollut­
ants that lead to acute admission to hospital 
and the chronic damage that causes long­
term effects. In fact, we should consider both 
of these as separate entities. However, we also 
should consider the effect of air pollution 
on newborns, which greatly depends on 
individual susceptibility—either congenital 
or acquired. This could play a major role in 
future outcomes and shed new light on the 
peculiar pathophysiological mechanisms of 
most pollution­related diseases. Clark et al. 
(2010) correctly outlined the asynchronism 
and the delay (0–4 years) between the initial 
pathogenetic exposure to pollutants (in utero 
or during the first year of life) and the occur­
rence and detectability of clinically relevant 
asthma. This further adds to the complexity 
of host­particle interactions.
There are three issues that should be 
taken into account in developmental epide­
miology studies such as that by Clark et al. 
(2010). First, epidemiological studies that 
concomitantly evaluate pollutant concen­
tration and detectable diseases or hospital 
admissions usually neglect the perinatal 
damage in fetuses and newborns, which is 
not immediately detectable but is a delayed 
manifestation. 
Second, perinatal damage from air pollu­
tion deserves further attention and detailed 
analysis because it includes fetal malforma­
tions, birth defects, and develop  mental altera­
tions of newborns. Injury from perinatal air 
pollution exposure could also be responsible 
for the increased proportion of unsusceptible 
individuals who, because of their exposure to 
pollutants during the susceptibility window 
and because of epigenetic alterations due to 
environmental factors, will become suscep­
tible. Epigenetic alterations could also transfer 
this susceptibility to future generations, lead­
ing to individuals developing not only asthma 
at 4 years of age but also respiratory, cardio­
vascular or systemic diseases ≥ 20 years later. 
Third, clinical and pathophysiological 
details are not “details” but basic issues and 
questions—still unsolved— that should be 
primary goals for future research. They are 
critical to improving design of epidemiologic 
studies and to selecting appropriate mod­
els, which should also include biological 
and pathophysiological parameters and vari­
ables because they significantly affect clinical 
outcomes.
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Editor’s note: In accordance with journal 
policy, Clark et al. were asked whether they 
wanted to respond to this letter, but they chose 
not to do so.
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